メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
谷木 信仁
内科学(消化器)
ウェブサイト
https://k-ris.keio.ac.jp/html/100002964_ja.html
h-index
1176
被引用数
15
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2012
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(48)
類似のプロファイル
(6)
フィンガープリント
Nobuhito Tanikiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Immunology and Microbiology
Mouse
100%
Macrophage
65%
Chemokine Receptor
56%
Concanavalin A
42%
Intestine Flora
42%
Primary Sclerosing Cholangitis
37%
Autoimmune Hepatitis
37%
Plasmacytoid Dendritic Cell
37%
CCR9
37%
Immune Tolerance
36%
Steatohepatitis
34%
Colitis
31%
Immune Response
29%
Innate Lymphoid Cell
28%
Hepatic Stellate Cell
25%
Autoimmunity
23%
Infectious Agent
23%
Transplant Procedure
21%
Small Intestine
20%
Murine
19%
Bacteriophage
18%
Klebsiella pneumoniae
18%
CD8
18%
T Helper 17 Cell
18%
CC Chemokine Receptors
18%
Liver Weight
18%
Bone Marrow-Derived Macrophage
18%
Memory T Cell
18%
Insulin Resistance
18%
Lactobacillus
18%
Monocyte
18%
Inflammatory Cytokine
18%
NKG2D
18%
Extracellular Matrix
18%
Regulatory T Cell
18%
interferon
18%
Granulocyte
18%
Apheresis
18%
Hepatitis A
18%
Gamma Chemokine
17%
Metabolite
16%
Cytokine Production
15%
Wild Type
14%
Dendritic Cell
14%
DNA Polymorphism
12%
Transgenic Mouse
12%
Wild Type Mouse
12%
Immunosuppressive Drug
10%
TLR9
9%
Cytotoxic T-Cell
9%
Medicine and Dentistry
Hepatocellular Carcinoma
66%
Fibrosis
45%
Liver Fibrosis
42%
Acute Liver Failure
42%
Gut
42%
Liver Transplantation
39%
Autoimmune Hepatitis
37%
Chemokine Receptor
37%
Nonalcoholic Fatty Liver
34%
Liver Tumor
33%
Observational Study
27%
Recurrent Disease
26%
Autoimmunity
23%
Collagen Type 4
21%
Liver Injury
21%
Antivirus Agent
21%
Pathogen
21%
Hepatic Stellate Cell
21%
Macrophage
21%
Thymoma
18%
Acute on Chronic Liver Failure
18%
CD8 Antigen
18%
Memory T Cell
18%
Alcohol Liver Cirrhosis
18%
Programmed Cell Death
18%
T Helper 17 Cell
18%
Metabolomics
18%
Paracetamol
18%
Gastroenterology
18%
Tolvaptan
18%
Beta Chemokine
18%
Primary Sclerosing Cholangitis
18%
Organ Dysfunction Score
18%
Sepsis
18%
Peginterferon
18%
Ribavirin
18%
Surgery
18%
Plasmapheresis
18%
Thorium Dioxide
18%
Simeprevir
18%
Hepatitis C
18%
Hepatobiliary Disease
18%
Predictive Factor
18%
Deep Sedation
18%
Thymectomy
18%
Disseminated Intravascular Coagulation
18%
Inflammatory Bowel Disease
18%
Immunoregulation
18%
Vagus Nerve
18%
Radiofrequency Ablation
18%
Keyphrases
Liver Injury
39%
Hepatocellular Carcinoma
37%
Japan
37%
Nationwide Survey
21%
Concanavalin A (Con A)
20%
Liver
20%
Acute-on-chronic Liver Failure
18%
Gut Pathobionts
18%
Interferon-free
18%
Triple Therapy
18%
Splenic B Cells
18%
Autoimmune Hepatitis
18%
Tissue-resident Memory T Cells
18%
Liver Fibrosis Resolution
18%
Simeprevir
18%
Pathogen Defense
18%
SARC-F
18%
Ribavirin
18%
Bone Marrow-derived Macrophages
18%
Thorotrast
18%
Chemokine Receptor 9
18%
Alcoholic
18%
Deep Sedation
18%
Brusatol
18%
Interleukin-15 (IL-15)
18%
Treatment Refractoriness
18%
Plasmacytoid Dendritic Cells
18%
Tissue-resident Macrophages
18%
Alcohol-related
18%
Living Donor Liver Transplantation
18%
Murine Liver
18%
CCR9
18%
Liver Fibrosis Marker
18%
Non-acetaminophen
18%
Internally Cooled Electrode
18%
Pegylated Interferon
18%
Type 1 Autoimmune Hepatitis
18%
Type I Autoimmune Hepatitis
18%
Cirrhotic Ascites
18%
Pathogenic Role
18%
Hypermetabolism
18%
Alcoholic Cirrhosis
18%
NKG2D
18%
CD3+ Lymphocytes
18%
Bacteriophage Therapy
18%
Meal Skipping
18%
Chronic Hepatitis C
18%
Nalmefene
18%
Significant Risk Factors
18%
Plasmacytoid DC
18%
